Co‐assembled Manganese‐CpG Nanoliposomes for Enhanced Immunotherapy against Colon Cancer Stem Cells
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202500545 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Weijian Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry & Life Science, Beijing University of Technology, NO. 100, Pingleyuan, Chaoyang, Beijing, 100124, P.R. China. Hauptthemen laut MEDLINE: Liposomes, Colonic Neoplasms, Manganese, Immunotherapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Nanovaccines represent a promising strategy for colon cancer immunotherapy, with the potential to elicit potent, tumor‐specific immune responses. However, the efficacy of these vaccines is often compromised by the presence of cancer stem cells (CSCs) in the tumor microenvironment (TME). Nanoliposome (NLP) is a widely used delivery system in nucleic acid and drug delivery research. In this study, we enriched MC38‐derived CSCs (MCSCs) and developed a manganese‐CpG‐nanoliposome (Mn@CpG@NLP) nanocomplex using MC38 colon carcinoma tumor lysates as antigens to induce immune responses against MCSCs‐derived tumors. Manganese NLPs (Mn@NLP) are initially engineered by incorporating manganese ions to enhance their positive surface charge, thereby optimizing their interaction with cellular membranes and activating the STING signaling pathway to promote bone marrow‐derived dendritic cells (BMDCs) maturation. Subsequently, these liposomes are co‐assembled with the CpG oligonucleotides (CpG ODNs) 1826 adjuvant, a Toll‐like receptor 9 agonist, through electrostatic interactions to form the Mn@CpG@NLP nano‐adjuvant complex. The Mn@CpG@NLP complex is efficiently taken up by dendritic cells (DCs), leading to their maturation and activation. This nanocomplex also effectively stimulated cytotoxic T lymphocytes and promoted the secretion of cytokines. In vivo treatment with Mn@CpG@NLP significantly inhibited tumor growth and prolonged survival in a mouse model. This study highlights the potential of nano‐adjuvant platforms in immunotherapy targeting cancers driven by colon CSCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry & Life Science, Beijing University of Technology, NO. 100, Pingleyuan, Chaoyang, Beijing, 100124, P.R. China.
- Department of Hepatobiliary Surgery, the second affiliated hospital of Jiaxing University, NO. 1518, Huancheng North Road, Jiaxing, 314000, P.R. China.
ORCID-Profile: Weijian Zhao, Wang Sheng
Förderung
- Innovative Research Group Project of the National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Zhao, W., Sun, S., He, X., Liu, Y., Meng, J., Hu, Q., Sheng, W., & Jia, R. (2025). Co‐assembled Manganese‐CpG Nanoliposomes for Enhanced Immunotherapy against Colon Cancer Stem Cells. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202500545
Vancouver
Zhao W, Sun S, He X, Liu Y, Meng J, Hu Q, et al. Co‐assembled Manganese‐CpG Nanoliposomes for Enhanced Immunotherapy against Colon Cancer Stem Cells. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202500545
BibTeX
@article{Zhao2025,
author = {Zhao, Weijian and Sun, Siyu and He, Xuesong and Liu, Yiran and Meng, Jing and Hu, Qin and Sheng, Wang and Jia, Runqing},
title = {Co‐assembled Manganese‐CpG Nanoliposomes for Enhanced Immunotherapy against Colon Cancer Stem Cells},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202500545}
}
EUVIMED